Inventor · disambiguated record
Nicholas Brian Raffaele
Also filed as: RAFFAELE NICHOLAS · RAFFAELE NICHOLAS B · RAFFAELE NICHOLAS BRIAN
13 granted patents·4 pending applications·39 citations·filing 2010–2025
89Inventor score
Files withMETABASIS THERAPEUTICS INC5H LUNDBECK AS4DART NEUROSCIENCE LLC3CYLENE PHARMACEUTICALS INC1HADDACH MUSTAPHA1
Top patents by PatentIndex Score
17 records- 0193US11434222B2MAGL inhibitorsH LUNDBECK AS·Filed 2021·Granted Sep 6, 2022·2 cites·12 claims
- 0290US12378219B2Crystalline forms of a MAGL inhibitorH LUNDBECK AS·Filed 2023·Granted Aug 5, 2025·1 cites·9 claims
- 0386US8962618B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofREDDY K RAJA·Filed 2012·Granted Feb 24, 2015·7 cites·6 claims
- 0485US10034891B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·2 cites·4 claims
- 0584US8575177B2Pyrazolopyrimidines and related heterocycles as CK2 inhibitorsHADDACH MUSTAPHA·Filed 2010·Granted Nov 5, 2013·12 cites·40 claims
- 0682US11434247B1Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Granted Sep 6, 2022·2 cites·24 claims
- 0782US9340566B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·2 cites·10 claims
- 0882US9303033B2Pyrazolopyrimidines and related heterocycles as CK2 inhibitorsSENHWA BIOSCIENCES INC·Filed 2013·Granted Apr 5, 2016·6 cites·44 claims
- 0979US8940927B2Activators of glucokinaseTIAN FENG·Filed 2011·Granted Jan 27, 2015·4 cites·31 claims
- 1078US2025145633A1Substituted furanopyrimidine compounds as pde1 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1176US10709718B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·1 cites·11 claims
- 1275US12006325B2Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Jun 11, 2024·0 cites·20 claims
- 1368US2025326737A1Crystalline forms of a magl inhibitorH LUNDBECK AS·Filed 2025·Application pending·0 cites
- 1465US2024018120A1Magl inhibitorsH LUNDBECK AS·Filed 2021·Application pending·0 cites
- 1559US9522926B2Activators of glucokinaseMETABASIS THERAPEUTICS INC·Filed 2014·Granted Dec 20, 2016·0 cites·56 claims
- 1651US10174062B2Activators of glucokinaseMETABASIS THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·0 cites·35 claims
- 1736US2011071115A1Pharmaceutically useful heterocycle-substituted lactamsCYLENE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas Brian Raffaele files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →